Amicus Therapeutics Inc (LTS:0HF9)
$ 10.0592 0.0812 (0.81%) Market Cap: 2.98 Bil Enterprise Value: 3.17 Bil PE Ratio: 0 PB Ratio: 16.66 GF Score: 81/100

Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2020 / 12:00PM GMT
Release Date Price: $10.19
Salveen Jaswal Richter
Goldman Sachs Group, Inc., Research Division - VP

Good morning. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and thank you so much for joining us for Day 2 of the 41st Annual Goldman Sachs Conference -- Healthcare Conference.

And with that, I just wanted to make a couple of disclosures before we start. We are required to make certain disclosures in public appearances about Goldman Sachs' relationships with companies that we discuss. The disclosures relate to investment banking relationships, compensation received or 1% or more ownership.

We are prepared to read aloud disclosures for any issuer upon request. However, these disclosures are available in the most recent reports available to you as clients at our firm portals. Disclosures and updates to these disclosures are also available by ticker on the firm's public website.

In addition, disclosures applicable to research with respect to companies, if any, mentioned herein are available through your investment representative. Further information on the subject companies may be obtained

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot